
    
      This protocol has two parts, Phase I Dose Finding and Phase 1 Expansion. Once the maximum
      tolerated dose has been identified in the Phase I Dose Finding portion, a Phase I expansion
      cohort of patients with metastatic or locally advanced unresectable kidney cancer will be
      enrolled.
    
  